FindTrial
Sign In

Supplementation of Vitamin C, Vitamin D3 and Zinc among Pulmonary tuberculosis patients at Puducherry

Effectiveness of supplementing Vitamin C, Vitamin D3 and Zinc among Pulmonary tuberculosis Adult patients at Puducherry - A Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098994
Enrollment
200
Registered
2025-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: CDZ - PTB: 1. T.Vitamin C 500mg OD x 60days (oral) 2. T.Vitamin D3 60K IU x 2months (weekly once) oral 3. T.Zinc 50mg OD x 60days (oral) 4. FDC - Vitamin C 500mg + Vitamin D3 2000 IU +

Sponsors

Dhivya SR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Sputum positive adults with drug sensitive tuberculosis above 18 years

Exclusion criteria

Exclusion criteria: Pregnancy, lactating mothers and those with known allergies or contraindication to study supplements

Design outcomes

Primary

MeasureTime frame
Cure rate by sputum confirmationTimepoint: After 2 months of treatment—

Secondary

MeasureTime frame
Reduction in inflammatory markers ( TNF - alpha & IL-6 )Timepoint: After 2 months of treatment—

Countries

India

Contacts

Public ContactDr Dhivya SR

Aarupadai Veedu Medical College and Hospital

sivaraj.rengaraj@avmc.edu.in9965646888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026